Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessing and Modulating Kynurenine Pathway Dynamics in Huntington’s Disease: Focus on Kynurenine 3-Monooxygenase
Korrapati V. Sathyasaikumar, Carlo Breda, Robert Schwarcz, et al.
Methods in molecular biology (2018), pp. 397-413
Closed Access | Times Cited: 9

Showing 9 citing articles:

Dynamic changes in metabolites of the kynurenine pathway in Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease: A systematic Review and meta-analysis
Mobina Fathi, Kimia Vakili, Shirin Yaghoobpoor, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition
Robert S. Phillips, Emma Carine Iradukunda, Tamera D. Hughes, et al.
Frontiers in Molecular Biosciences (2019) Vol. 6
Open Access | Times Cited: 47
Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease
Filipe B. Rodrigues, Lauren M. Byrne, Alexander J. Lowe, et al.
Journal of Neurochemistry (2021) Vol. 158, Iss. 2, pp. 539-553
Open Access | Times Cited: 28
Cellular Localization of Kynurenine 3-Monooxygenase in the Brain: Challenging the Dogma
Korrapati V. Sathyasaikumar, Verónica Pérez de la Cruz, Benjamín Pineda, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 315-315
Open Access | Times Cited: 19
Kynurenine‐3‐monooxygenase: A new direction for the treatment in different diseases
Yifei Lü, Mingmei Shao, Tao Wu
Food Science & Nutrition (2020) Vol. 8, Iss. 2, pp. 711-719
Open Access | Times Cited: 21
Pyrimidine analogues for the management of neurodegenerative diseases
Swati Pant, Anandi Kapri, Sumitra Nain
European Journal of Medicinal Chemistry Reports (2022) Vol. 6, pp. 100095-100095
Open Access | Times Cited: 10
Role of Lipid Peroxidation Process in Neurodegenerative Disorders
Arunachalam Muthuraman, Narahari Rishitha, Nallupillai Paramakrishnan, et al.
IntechOpen eBooks (2019)
Open Access | Times Cited: 10
LatentToxoplasma gondiiinfection increases soluble mutant huntingtin and promotes neurodegeneration in the YAC128 mouse model of Huntington’s disease
David W. Donley, Teal Jenkins, Cailin Deiter, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 1
Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington’s disease
Filipe B. Rodrigues, Lauren M. Byrne, Alexander J. Lowe, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access
Page 1

Scroll to top